Iontophoresis of nafarelin across human skin in vitro. 1996

A M Rodríguez Bayón, and R H Guy
Departamento de Farmacia y Tecnologia Farmaceutica, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.

UI MeSH Term Description Entries
D007478 Iontophoresis Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current. Iontophoreses
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012869 Skin Absorption Uptake of substances through the SKIN. Absorption, Skin,Intracutaneous Absorption,Intradermal Absorption,Percutaneous Absorption,Transcutaneous Absorption,Transdermal Absorption,Absorption, Intracutaneous,Absorption, Intradermal,Absorption, Percutaneous,Absorption, Transcutaneous,Absorption, Transdermal,Absorptions, Intracutaneous,Absorptions, Intradermal,Absorptions, Percutaneous,Absorptions, Skin,Absorptions, Transcutaneous,Absorptions, Transdermal,Intracutaneous Absorptions,Intradermal Absorptions,Percutaneous Absorptions,Skin Absorptions,Transcutaneous Absorptions,Transdermal Absorptions
D017274 Nafarelin A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS. Nafarelin Acetate,Nafarelin Acetate, Hydrate,Nafarelin Monoacetate,RS-94991-298,Synarel,RS 94991 298,RS94991298
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

A M Rodríguez Bayón, and R H Guy
January 2009, Pharmaceutical development and technology,
A M Rodríguez Bayón, and R H Guy
February 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
A M Rodríguez Bayón, and R H Guy
November 1995, Journal of pharmaceutical sciences,
A M Rodríguez Bayón, and R H Guy
October 2004, Journal of pharmaceutical sciences,
A M Rodríguez Bayón, and R H Guy
January 1998, Journal of controlled release : official journal of the Controlled Release Society,
A M Rodríguez Bayón, and R H Guy
November 1993, Journal of pharmaceutical sciences,
A M Rodríguez Bayón, and R H Guy
September 1993, Pharmaceutical research,
A M Rodríguez Bayón, and R H Guy
March 2005, Journal of controlled release : official journal of the Controlled Release Society,
A M Rodríguez Bayón, and R H Guy
November 2003, International journal of pharmaceutics,
Copied contents to your clipboard!